Pyrazoline: A Promising Scaffold for the Inhibition of Monoamine Oxidase

E-ISSN： 1875-6166|13|3|195-206

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.13, Iss.3, 2013-09, pp. : 195-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 20, 2012-10 ,pp. : 2240-2257

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase Inhibition and Molecular Modeling Studies of Piperidyl-thienyl and 2-Pyrazoline Derivatives of Chalcones

Medicinal Chemistry, Vol. 11, Iss. 5, 2015-01 ,pp. : 497-505

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase Inhibition and CNS Immunodeficiency Infection

By Koutsilieri E. Scheller C. ter Meulen V. Riederer P.

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 267-270

Elsevier

Access to resources Recommend Favorite

Monoamine Oxidase-B Inhibition in Alzheimer's Disease

By Riederer P. Danielczyk W. Grunblatt E.

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Exploring Nitrostyrene as a Scaffold for a New Class a of Monoamine Oxidase Inhibitors

Letters in Drug Design & Discovery, Vol. 9, Iss. 10, 2012-01 ,pp. : 958-961

Bentham Science Publishers

Access to resources Recommend Favorite